AARP: Brand Name Drug Retail Prices Skyrocketing

WASHINGTON–(ENEWSPF)–August 27, 2010.  AARP’s first-ever analysis of retail price trends of prescription drugs finds prices for widely used brand name drugs skyrocketed in 2009, climbing more than eight percent even as general inflation remained negative.  The AARP Rx Price Watch report findings align with the Association’s earlier Rx Watchdog reports, which found similarly large increases in manufacturer prices for brand name drugs.